The incidence of opioid-associated cardiac arrest increased significantly from 2012 to 2018, according to a study presented at the European Society of Cardiology Congress 2021: The Digital Experience.
Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
Investigators conducted a pilot feasibility study on the effects of an internet-based CBT program on symptoms of pain in patients with chronic pancreatitis.
Within individual health systems, Black and White patients receive markedly different opioid doses.
The researchers evaluated how an opioid restriction law in Florida affected the use of prescription NSAIDs.
For patients with untreated opioid use disorder (OUD) presenting to the emergency department, high-dose buprenorphine induction seems safe and is well tolerated.
The prevalence of medication use for treatment of opioid use disorder increased from 2014 through 2018 among US Medicaid enrollees in 11 states.
From 2008 to 2018, there was a sharp increase in methamphetamine-associated cardiomyopathy/heart failure hospitalizations and related costs in California.
A team of investigators conducted a Delphi study to provide evidence-based guidance to clinicians about management and care of patients with serious illnesses who misuse opioids or have opioid use disorder.
Drug overdose deaths in the United States rose nearly 30 percent in 2020, according to provisional data released by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.
